Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$2.16 - $3.18 $120,687 - $177,679
-55,874 Closed
0 $0
Q1 2021

May 18, 2021

SELL
$2.89 - $4.22 $9,427 - $13,765
-3,262 Reduced 5.52%
55,874 $168,000
Q4 2020

Feb 16, 2021

BUY
$2.69 - $4.24 $12,018 - $18,944
4,468 Added 8.17%
59,136 $222,000
Q3 2020

Nov 17, 2020

BUY
$3.07 - $5.0 $4,595 - $7,485
1,497 Added 2.82%
54,668 $168,000
Q1 2020

May 13, 2020

BUY
$1.83 - $5.41 $1,101 - $3,256
602 Added 1.15%
53,171 $121,000
Q4 2018

Feb 13, 2019

BUY
$8.47 - $14.71 $6,547 - $11,370
773 Added 1.49%
52,569 $498,000
Q3 2018

Nov 14, 2018

BUY
$13.7 - $17.12 $4,726 - $5,906
345 Added 0.67%
51,796 $746,000
Q2 2018

Aug 14, 2018

BUY
$14.63 - $19.19 $752,728 - $987,344
51,451 New
51,451 $830,000

Others Institutions Holding GLYC

About GLYCOMIMETICS INC


  • Ticker GLYC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,423,900
  • Market Cap $14.7M
  • Description
  • GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...
More about GLYC
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.